USDL to buy stakes in center firms
Imaging services firm US Diagnostic Labs has signed agreementsto buy controlling interests in two center companies, one a multimodalityimaging center and the other a radiation therapy company. USDL of West Palm Beach, FL, announced this month that it
Imaging services firm US Diagnostic Labs has signed agreementsto buy controlling interests in two center companies, one a multimodalityimaging center and the other a radiation therapy company.
USDL of West Palm Beach, FL, announced this month that it intendsto purchase an 80% stake in Charleston Diagnostic Imaging of Charleston,SC. The center has revenues of $3.6 million and net income ofover $800,000 annually.
In addition, USDL agreed to buy a 50.1% interest in RadiationOncology Centers for $2.6 million. ROC operates three radiationtherapy centers in Northern California. USDL, which manages 15wholly owned or majority-owned centers, said that it intends toexpand into oncology practice management.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.
Chest CT for Post-COVID-19 Abnormalities: Nine Takeaways from a Multi-Society Consensus Statement
July 22nd 2025Developed by 21 thoracic radiologists, the new international consensus statement addresses appropriate indications, scan acquisition and keys to reporting for the use of chest CT imaging in evaluating for residual lung abnormalities from COVID-19.
